Target intelligence / Profile preview

BCL2 interacting protein 3 pseudogene 9 (BNIP3P9)

Target
BNIP3P9
Molecular classification
Other (pseudogene)
01

Overview

BCL2 interacting protein 3 pseudogene 9 (BNIP3P9) is annotated as a pseudogene, meaning it is a DNA sequence that closely resembles a known functional gene (in this case, BNIP3), but contains disabling mutations or lacks regulatory elements necessary for expression, so it does not encode a functional protein[1][5][11][14]. Pseudogenes like BNIP3P9 may be transcribed in some circumstances but typically do not exert biological effects at the protein level. They are not considered disease targets or functional molecules such as receptors, enzymes, or transporters. While the parental BNIP3 gene encodes a mitochondrial protein involved in apoptosis and autophagy, pseudogenes such as BNIP3P9 do not share these functions[3][4][7]. Some pseudogenes can have regulatory RNA-based roles (acting as microRNA sponges or antisense transcripts), but there is no evidence for BNIP3P9 having such activity[8][14]. In summary, BNIP3P9 is best described as a non-functional genomic element derived from BNIP3, with no established protein product or therapeutic role.

Other names
BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 9BNIP3P9

Beyond the preview

Go deeper on BCL2 interacting protein 3 pseudogene 9 (BNIP3P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 9 (BNIP3P9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call